***SCANCELL'S DYNAMITE REVELATION*** In May 2010 an astonishing revelation came to light. Scancell was to trial a vaccine that, in an earlier version, had already cured two girls of bone cancer! The elder of the two wished to remain anonymous but Amy Dickenson, by now 20 years old and pregnant with her second baby, was only too pleased to bear witness to the miracle cure which saved her life. As an eight year old, Amy was entered into a trial of the early version of Scancell's vaccine, configured at that time to treat bone cancer. In Amy's case an advanced stage of this cancer had developed in her left leg. Despite gruelling surgery and chemotherapy, the disease persisted and spread to her lungs. Amy was not expected to survive, yet she was found to be cured following the treatment. Professor Kathy Pritchard Jones, who led the trial with both girls, at the Royal Marsden Hospital in London, said: “I believe the vaccine played a vital role in their recovery. It is incredibly promising that patients with this almost incurable disease have gone on to live normal lives.” Scancell is currently engaged in new clinical trials with the latest version of the vaccine reconfigured to treat malignant melanoma, the most aggressive form of skin cancer. Designated SCIB1, this will be the first vaccine Scancell has designed for commercial use. A second vaccine to treat lung cancer is also in development. Professor Lindy Durrant, Joint CEO of Scancell commented: "In the short term, this could cure some patients with the disease, and in the long term it could be used to prevent people developing it in the first place." Professor Karol Sikora, a leading cancer expert, added: "This is a very clever vaccine and I believe it will increase the cure rate for patients in the future." *THE SUNDAY EXPRESS* [link]-scientists-hail-huge-leap-towards-jab-that-targets-tumours